Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02290951 |
|---|---|
| Brief Title: | Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies (ELM-1) |
| First Submitted : | November 7, 2014 |
| First Submitted that Met QC Criteria : | November 11, 2014 |
| First Posted : | November 14, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 6, 2023 |
| Last Update Posted : | September 7, 2023 |